AstraZeneca's David Brennan - CEO Pay
David Brennan - AstraZeneca
Total Compensation: $4.7M
Details: So much for those rumors that Brennan turned down a double-digit pay increase. The CEO's compensation bounced back from 2007's 19 percent drop, with his total 2008 salary of £2.51 million ($4.7 million) coming in at a 17 percent increase over 2007. Brennan's base salary dropped from 2007's $2 million to 1.8 million in 2008, but his bonus jumped from $2,016,000 to $2,425,000. He also received $406,000 in allowances, which included a car, relocation funds and cash for a vested performance share plan award.
AstraZeneca News:
AZ's Brennan sees "top-line" challenges ahead
AstraZeneca - Top 5 layoffs of 2008
AZ nabs more uses for Seroquel XR
AZ's Brennan tries to conceal Crestor glee
AZ's expanded China focus pays off
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: